High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma
Clinical trial NCT00283556 · COMPLETED
Trial details
- NCT number
- NCT00283556
- Sponsor
- Kentuckiana Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Primary completion
- 2008-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.